1 / 8

Dr David Greene Arizona Parkinson's Disease Treatment

Pain becomes increasingly severe in Parkinson's disease, a neurological condition. It affects about 1% of seniors 60 years or older in industrialized nations. Reliable Source Experts like Dr. David Greene Arizona believe that inherited and environmental factors may be involved, even if the exact cause of the condition remains unknown. Dopamine levels decrease due to Parkinson's disease-related neuronal death in particular brain areas. For more information, visit our website. <br>

drdavidgreenearizona
Download Presentation

Dr David Greene Arizona Parkinson's Disease Treatment

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. DR DAVID GREENE ARIZONA | PARKINSON'S DISEASE TREATMENT We help doctors provide the best possible patient care.

  2. About. A neurological condition called Parkinson's disease is characterized by increasingly severe pain. It affects about 1% of seniors 60 years or older in industrialized nations. Reliable Source Experts like Dr. David Greene Arizona believe that inherited and environmental factors may be involved, even if the exact cause of the condition remains unknown. Dopamine levels decrease due to Parkinson's disease-related neuronal death in particular brain areas.

  3. What have clinical trials found? Before developing the technique for creating iPSCs, the only stem cell therapy for Parkinson's disease involved embryonic stem cells. However, this created moral and practical issues, which made the research process more challenging.

  4. Trials have shown improvement in both movement problems and non-motor symptoms, such as bladder control. There are various challenges in the stem cell's place of origin. Using stem cells is comparable to transplanting an organ. However, experts believe that this will delay stem cell therapy while the iPSCs are being developed in the lab. In addition, this will be more expensive than a donor's validated, proven line of iPSCs.

  5. Logo Here What will the further generation of clinical trials focus on? There are several Parkinson's disease symptoms. As a result, the Movement Disorder Society's MDS-UPDRS, an updated version of the Unified Parkinson's Disease Rating Scale (UPDRS), is widely used to assess them. Today's clinical trials aim to significantly increase individuals with Parkinson's disease's UPDRS or MDS-UPDRS scores.

  6. Takeaway The objective of stem cell therapy for Parkinson's disease is to replace harmed brain cells with fresh, undifferentiated stem cells. As they mature into brain cells, these stem cells may then control your dopamine levels. This can dramatically lessen several Parkinson's disease symptoms, according to doctors.

  7. Dr. David Greene Arizona, a stem cell researcher, is working to provide experimental treatments for patients with serious ailments. For example, he demonstrates how doctors have treatments to help you manage your Parkinson's symptoms.

  8. THANK YOU 239-263-8444 www.r3stemcell.com 1112 Goodlette Road North, Suite 203

More Related